Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| JPMorgan Chase & Co.COMMON EQUITY(JPM) | 379,000 | 429,000 | +50,000 | $109.9K | $135.3K | 26.07% | +$25.4K |
| American Express CompanyCOMMON EQUITY(AXP) | 197,215 | 247,215 | +50,000 | $62.9K | $82.1K | 15.82% | +$19.2K |
| The Progressive CorporationCOMMON EQUITY(PGR) | 182,000 | 182,000 | 0 | $48.6K | $44.9K | 8.66% | -$3.6K |
| Mastercard IncorporatedCOMMON EQUITY(MA) | 68,000 | 68,000 | 0 | $38.2K | $38.7K | 7.45% | +$467 |
| KKR & Co. Inc.COMMON EQUITY(KKR) | 91,000 | 271,000 | +180,000 | $12.1K | $35.2K | 6.78% | +$23.1K |
| Berkshire Hathaway Inc Cl ACOMMON EQUITY | 44 | 44 | 0 | $32.1K | $33.2K | 6.39% | +$1.1K |
| Accenture Plc Cl ACOMMON EQUITY SHS CLASS A | 15,000 | 115,000 | +100,000 | $4.5K | $28.4K | 5.46% | +$23.9K |
| U.S. BancorpCOMMON EQUITY(USB) | 558,000 | 558,000 | 0 | $25.2K | $27.0K | 5.19% | +$1.7K |
| Western Alliance BancorporationCOMMON EQUITY(WAL) | 285,000 | 285,000 | 0 | $22.2K | $24.7K | 4.76% | +$2.5K |
| The Goldman Sachs Group, Inc.COMMON EQUITY(GS) | 25,000 | 25,000 | 0 | $17.7K | $19.9K | 3.84% | +$2.2K |
| Aon plcCOMMON EQUITY(AON) | 49,000 | 49,000 | 0 | $17.5K | $17.5K | 3.37% | -$9 |
| Arch Capital Group LtdCOMMON EQUITY ORD | 150,000 | 150,000 | 0 | $13.7K | $13.6K | 2.62% | -$48 |
| Alibaba Group Holding LimitedCOMMON EQUITY(BABA) | 50,000 | 50,000 | 0 | $5.7K | $8.9K | 1.72% | +$3.3K |
| Global Payments Inc.COMMON EQUITY(GPN) | 68,000 | 68,000 | 0 | $5.4K | $5.6K | 1.09% | +$206 |
| Northern Trust CorporationCOMMON EQUITY(NTRS) | 30,000 | 30,000 | 0 | $3.8K | $4.0K | 0.78% | +$234 |
| Bank OZKCOMMON EQUITY(OZK) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Citigroup Inc.COMMON EQUITY(C) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Cadence BancorpCOMMON EQUITY | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Wells Fargo & CompanyCOMMON EQUITY(WFC) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| The Charles Schwab CorporationCOMMON EQUITY(SCHW) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Amryt Pharma Ltd - Spnr AdrCOMMON EQUITY | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Atai Lifesciences NvCOMMON EQUITY | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Kaleyra IncCOMMON EQUITY | 0 | 0 | 0 | $0 | $0 | — | $0 |